Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres f...
Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's&...
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduces a novel drug comb...
Gilead Sciences, Inc. has recently announced that with effect from 1 May 2019, Vemlidy (tenofovir alafenamide, TAF)...
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary ...
Roche has declared that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII in...
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...
Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has r...
StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...
HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...
BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antib...
Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with mod...
Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antide...
Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-con...
Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review...
